Congratulations to our spinoff company, Larkspur Biosciences on closing the recent $35.5 million financing round!
The #biotech company is spearheading a groundbreaking mission to revolutionize #cancer treatment, working on developing cutting-edge precision #immunotherapies that have the power to outsmart cancer by specifically targeting the devious ways tumors hijack the immune system.
Wednesday, May 24, 2023
